Summit Securities Group’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Summit Securities Group's AMGN Position: Q3 2026 in Review
Summit Securities Group opened a new position in Amgen (AMGN) in Q3 2026: 675 shares worth $285K. The stake represents 0.03% of the portfolio and ranks #280 among its holdings. This is a return to the name: Summit Securities Group previously reported a position in AMGN as recently as Q1 2026.
Summit Securities Group first reported a position in AMGN in Q2 2013 and has held it in 40 quarters since. The position peaked at $3.71M in Q3 2022. 2,911 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.
- Summit Securities Group held 675 shares of Amgen worth $285K as of Q3 2026.
- Amgen was a new Summit Securities Group position in Q3 2026.
- Amgen made up 0.03% of Summit Securities Group's portfolio in Q3 2026, its #280 holding.
- Summit Securities Group first reported a position in Amgen in Q2 2013 and has held it in 40 quarters since.
- Summit Securities Group's Amgen position peaked at $3.71M in Q3 2022.
- 2,911 funds tracked by Wall St. Rank held Amgen as of Q3 2026.
Based on Summit Securities Group's 13F filing for Q3 2026, filed 5 Nov 2026.